Cargando…

RNA Interference Approach Is a Good Strategy against SARS-CoV-2

COVID-19, caused by SARS-CoV-2, created a devastating outbreak worldwide and consequently became a global health concern. However, no verifiable, specifically targeted treatment has been devised for COVID-19. Several emerging vaccines have been used, but protection has not been satisfactory. The com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ying-Ray, Tsai, Huey-Pin, Yeh, Chun-Sheng, Fang, Chiung-Yao, Chan, Michael W. Y., Wu, Tzu-Yun, Shen, Cheng-Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862891/ https://www.ncbi.nlm.nih.gov/pubmed/36680140 http://dx.doi.org/10.3390/v15010100

Ejemplares similares

RNA interference as a promising treatment against SARS-CoV-2
por: Donia, Ahmed, et al.
Publicado: (2020)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Novel Software for High-level Virological Testing: Self-Designed Immersive Virtual Reality Training Approach
por: Tsai, Huey-Pin, et al.
Publicado: (2023)

Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19
por: Ho, Hui-Min, et al.
Publicado: (2021)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Increasing Cytomegalovirus Detection Rate from Respiratory Tract Specimens by a New Laboratory-Developed Automated Molecular Diagnostic Test
por: Tsai, Huey-Pin, et al.
Publicado: (2020)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Unravelling the origin of SARS-CoV-2: is the model good?
por: Frutos, R., et al.
Publicado: (2021)

Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus
por: Sitjar, Jaya, et al.
Publicado: (2022)

Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies
por: Hsieh, Wen-Yeh, et al.
Publicado: (2021)

Highly-specific aptamer targeting SARS-CoV-2 S1 protein screened on an automatic integrated microfluidic system for COVID-19 diagnosis
por: Wu, Hung-Bin, et al.
Publicado: (2023)

The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2
por: Lopez-Orozco, Joaquin, et al.
Publicado: (2023)

Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study
por: Liu, Ping-Yen, et al.
Publicado: (2020)

Targets and strategies for vaccine development against SARS-CoV-2
por: Malik, Jonaid Ahmad, et al.
Publicado: (2021)

Challenges of SERS technology as a non-nucleic acid or -antigen detection method for SARS-CoV-2 virus and its variants
por: Sitjar, Jaya, et al.
Publicado: (2021)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

Performance of SARS-CoV-2 serology tests: Are they good enough?
por: Piec, Isabelle, et al.
Publicado: (2021)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
por: Jeong, Gi Uk, et al.
Publicado: (2020)

Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy
por: Chiang, Chen-Yi, et al.
Publicado: (2022)

Development of leading first-generation vaccines against SARS-CoV-2
por: Perera, Pin-Yu, et al.
Publicado: (2021)

Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker?
por: Comentale, Giuseppe, et al.
Publicado: (2020)

Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS‐CoV‐2
por: Hu, Xiumei, et al.
Publicado: (2020)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

An efficient RNA interference screening strategy for gene functional analysis
por: Chang, Chih-Hung, et al.
Publicado: (2012)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022)

Strategies that reduce Stroop interference
por: Palfi, B., et al.
Publicado: (2022)

The SARS-Cov-2 Pandemic: A Good Time for Stem Cell Transplantation?
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
por: de Marco, Ario, et al.
Publicado: (2022)

SARS‐CoV‐2 and immunosuppressors at cellular level: Some good news
por: Abreu, Candida
Publicado: (2023)

A Multi-Stage Green Barrier Strategy for the Control of Global SARS-CoV-2 Transmission via Cold Chain Goods
por: He, Xu, et al.
Publicado: (2022)

Protective Effect of Vaccine Doses and Antibody Titers Against SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Chen, Chien-Chia, et al.
Publicado: (2023)

Combining Desirable Traits for a Good Biocontrol Strategy against Sclerotinia sclerotiorum
por: Albert, Daphné, et al.
Publicado: (2022)

Prospects of Coffee Leaf against SARS-CoV-2 Infection
por: Wu, Chen-Shiou, et al.
Publicado: (2022)

A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
por: Lee, Nan-Yao, et al.
Publicado: (2020)

Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
por: Shen, Kuan‐Yin, et al.
Publicado: (2022)

Detection of live SARS-CoV-2 virus and its variants by specially designed SERS-active substrates and spectroscopic analyses
por: Sitjar, Jaya, et al.
Publicado: (2023)

Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference
por: Zhang, Yuanjiang, et al.
Publicado: (2004)

The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
por: Purcaru, Oana-Stefana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e4cpmc3idghoagphqoaevq1i4i